Lantheus Holdings, Inc. Deferred Income Tax Assets, Net
Lantheus Holdings, Inc. (LNTH) had Deferred Income Tax Assets, Net of $102.72 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-08-06
- 2026-06-30: Deferred Income Tax Assets, Net $102.72M.
- 2026-03-31: Deferred Income Tax Assets, Net $89.12M.
- 2025-12-31: Deferred Income Tax Assets, Net $109.20M.
- 2025-09-30: Deferred Income Tax Assets, Net $107.45M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-06-30 | $102.72M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $89.12M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $109.20M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $107.45M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $138.26M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $168.88M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $170.23M 10-K · filed 2026-02-26 |
| 2024-09-30 | $144.64M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $151.19M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $138.90M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $150.20M 10-K · filed 2025-02-26 |
| 2023-09-30 | $152.19M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $134.20M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $133.87M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $110.65M 10-K · filed 2024-02-22 |
| 2022-09-30 | $46.81M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $55.16M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $47.87M 10-Q · filed 2022-04-29 |
| 2021-12-31 | $62.76M 10-K · filed 2023-02-23 |
| 2021-09-30 | $66.49M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $64.78M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $62.83M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $70.15M 10-K · filed 2022-02-24 |
| 2020-09-30 | $69.34M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $67.44M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $70.45M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $71.83M 10-K · filed 2021-02-25 |
| 2019-09-30 | $77.75M 10-Q · filed 2019-10-31 |
| 2018-12-31 | $81.45M 10-K · filed 2020-02-25 |
| 2018-09-30 | $79.36M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $82.04M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $83.66M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $87.01M 10-K · filed 2019-02-20 |
| 2016-12-31 | $65.00K 10-K · filed 2018-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |